StockRating News & Analysis

5 articles

Market Mood

1 Bullish3 Neutral1 Bearish
H.C. Wainwright Maintains Neutral Rating on Phunware Stock at $2
TechNeutral3/25/2026

H.C. Wainwright Maintains Neutral Rating on Phunware Stock at $2

H.C. Wainwright has reiterated a Neutral rating for Phunware Inc., maintaining the stock price target at $2. This rating reflects the firm's outlook on the company's performance and its implications for investors. The stability in the rating might influence market perceptions of Phunware's stock, particularly among analysts and investors monitoring tech sector stocks.

Read More
H.C. Wainwright Reiterates Buy Rating on Achieve Life Sciences Stock
EarningsBullish3/25/2026

H.C. Wainwright Reiterates Buy Rating on Achieve Life Sciences Stock

H.C. Wainwright has reaffirmed a 'Buy' rating on Achieve Life Sciences, indicating confidence in the stock's performance. The analyst believes this position reflects solid growth potential for the company’s portfolio. Specific price targets or trading volumes were not disclosed in the report. The reiteration comes amidst ongoing developments in the pharmaceutical sector, which could impact market sentiment toward biotech stocks.

Read More
Cantor Fitzgerald Maintains Neutral Rating on Rezolute Stock Post FDA Meeting
EarningsNeutral3/25/2026

Cantor Fitzgerald Maintains Neutral Rating on Rezolute Stock Post FDA Meeting

Cantor Fitzgerald has reaffirmed a Neutral rating for Rezolute stock following a meeting with the FDA. The outcome of this meeting is essential for the company's future prospects, as FDA decisions can significantly impact stock performance and investor sentiment. The company's market position remains unchanged, suggesting no immediate catalyst for upward or downward movement in stock prices. Continuous monitoring of FDA interactions is advisable for investors looking at Rezolute.

Read More
Raymond James Downgrades AG Growth Following Weak Earnings Results
EarningsBearish3/25/2026

Raymond James Downgrades AG Growth Following Weak Earnings Results

Raymond James has downgraded its rating on AG Growth stock due to the company's recent disappointing financial results. Specific metrics regarding earnings or revenue were not disclosed in the headline, but the downgrade appears to reflect broader concerns about the company's performance. This action may impact investor sentiment and stock activity regarding AG Growth and the agricultural equipment sector. Monitoring trading volumes and stock price movements for AG Growth will be crucial following this downgrade.

Read More
Jefferies Maintains Pinduoduo Stock Rating Following Q4 Results
EarningsNeutral3/25/2026

Jefferies Maintains Pinduoduo Stock Rating Following Q4 Results

Jefferies has reaffirmed its stock rating for Pinduoduo after the company's Q4 results. The specifics of the earnings report and any changes in revenue or earnings per share (EPS) have not been disclosed in this summary. This decision reflects Jefferies' assessment of Pinduoduo's performance and expectations moving forward, indicating stability in the stock's outlook. The market reaction to this reiteration could influence investor sentiment and trading volumes.

Read More